S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
NASDAQ:BSGM

BioSig Technologies Earnings Date, Estimates, & History

$2.52
+0.02 (+0.80 %)
(As of 10/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.32
$2.56
50-Day Range
$2.42
$3.23
52-Week Range
$2.26
$6.14
Volume
90,932 shs
Average Volume
271,171 shs
Market Capitalization
$88.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.74

Earnings Summary

Upcoming
Earnings Date
Nov. 4
Estimated

Actual EPS
(Aug. 10)
-$0.24
Beat By $0.02

Consensus EPS
(Aug. 10)
-$0.26

Last Year's Q3 EPS
(8/6/2020)
-$0.72

Skip Charts & View Estimated and Actual Earnings Data

BioSig Technologies Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BioSig Technologies Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BSGM Earnings Information

BioSig Technologies last announced its earnings results on August 10th, 2021. The reported ($0.24) earnings per share for the quarter, beating the consensus estimate of ($0.26) by $0.02. The business had revenue of $0.21 million for the quarter. BioSig Technologies has generated $0.00 earnings per share over the last year (($1.19) diluted earnings per share). BioSig Technologies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 4th, 2021 based off prior year's report dates.

BioSig Technologies (NASDAQ:BSGM) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
11/4/2021
(Estimated)
        
8/10/2021Q2($0.26)($0.24)+$0.02($0.24)$0.21 million
5/17/2021Q1 2021($0.26)($0.26)($0.26)$0.12 million
3/15/2021Q4 2020($0.31)($0.31)($0.31)
11/5/2020Q3 2020($0.38)($0.38)($0.38)
8/6/2020Q2 2020($0.72)($0.72)($0.72)
5/11/2020Q1($0.24)($0.46)($0.22)($0.46)
3/13/2020Q4 2019($0.69)($0.69)($0.69)
10/23/2019Q3 2019($0.25)($0.25)($0.25)
7/31/2019Q2 2019($0.38)($0.38)($0.38)
4/15/2019Q1 2019($0.30)($0.3289)($0.0289)($0.33)
7/27/2018Q2 2018($0.45)($0.45)($0.45)
7/27/2018Q2 2018($0.45)($0.45)($0.45)
5/4/2018Q1 2018($0.23)($0.23)($0.23)
5/4/2018Q1 2018($0.09)($0.09)($0.09)
8/10/2017Q2 2017($0.30)($0.30)($0.30)
8/10/2017Q2 2017($0.12)($0.12)($0.12)
5/9/2017Q1 2017($0.35)($0.35)($0.35)
5/9/2017Q1 2017($0.14)($0.14)($0.14)
3/30/2017Q4 2016($0.13)($0.13)($0.13)
3/30/2017Q4 2016($0.05)($0.05)($0.05)
11/14/2016Q3 2016($0.20)($0.20)($0.20)
11/14/2016Q3 2016($0.08)($0.08)($0.08)
8/12/2016Q2 2016($0.80)($0.80)($0.80)
8/12/2016Q2($0.32)($0.32)($0.32)
5/4/2016Q1 2016($0.38)($0.38)($0.38)
5/4/2016Q1 2016($0.15)($0.15)($0.15)
3/14/2016Q4 2015($0.33)($0.33)($0.33)
3/14/2016Q4 2015($0.13)($0.13)($0.13)
11/13/2015Q3 2015($0.43)($0.43)($0.91)
11/13/2015Q3 2015($0.17)($0.17)($0.36)
(Earnings results data provided by Zacks Investment Research)












BioSig Technologies (NASDAQ:BSGM) Earnings Frequently Asked Questions

When is BioSig Technologies's earnings date?

BioSig Technologies has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 4th, 2021 based off last year's report dates. Learn more on BSGM's earnings history

Did BioSig Technologies beat their earnings estimates last quarter?

In the previous quarter, BioSig Technologies (NASDAQ:BSGM) reported ($0.24) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.26) by $0.02. Learn more on BSGM's earnings details

How much profit does BioSig Technologies generate each year?

BioSig Technologies (NASDAQ:BSGM) has a recorded net income of -$52.22 million. BSGM has generated $0.00 earnings per share over the last four quarters.

This page was last updated on 10/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.